Literature DB >> 9396417

Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation.

M Murata1, Y Matsubara, K Kawano, T Zama, N Aoki, H Yoshino, G Watanabe, K Ishikawa, Y Ikeda.   

Abstract

BACKGROUND: Platelets play pivotal roles in coronary thrombosis, and antiplatelet therapies are widely used for coronary artery disease (CAD). However, the effects of genetic variation in platelets on CAD are poorly understood. We have assessed the association between CAD and polymorphisms in a platelet receptor for von Willebrand factor, the glycoprotein (GP) Ib/IX complex, which mediates shear stress-dependent platelet activation. METHODS AND
RESULTS: Genotypes of the alpha-chain of the receptor (GP Ib alpha, 145Thr/Met) were determined in 91 patients with myocardial infarction (MI) or angina pectoris whose lesions were confirmed by coronary angiography as well as in 105 individuals from the general population with no history of angina or other heart diseases and normal resting ECGs. There was no homozygote for Met/Met in either the control or patient groups. The prevalence of the Thr/Met genotype (T/M) in all patients was not significantly different from that in the control group. However, the frequency of T/M was significantly higher in patients aged < or = 60 years (31.8%) than in control subjects aged < or = 60 years (16.0%; P<.05, odds ratio=2.5). An association was also demonstrated between CAD and the other polymorphism of GP Ib alpha, a variable number of tandem repeats of a 13-amino acid sequence, which is known to be linked to the 145Thr/Met polymorphism. There was an association between the frequency of the T/M genotype and the angiographic severity of CAD: 11.1% for Gensini score < 40 versus 50.0% for Gensini score > or = 40 (P=.0015). There was no difference in the distribution of GP Ib alpha genotypes between patients with MI and those with angina pectoris.
CONCLUSIONS: This study suggests that the presence of the Met allele in GP Ib alpha is a risk factor for the prevalence and severity of CAD in individuals aged < or = 60 years. The results need to be confirmed in a large-scale study of incident case subjects and matching control subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396417     DOI: 10.1161/01.cir.96.10.3281

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients.

Authors:  Dermot Kenny; Clare Muckian; Desmond J Fitzgerald; Christopher P Cannon; Denis C Shields
Journal:  J Thromb Thrombolysis       Date:  2002-02       Impact factor: 2.300

Review 3.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

Review 4.  Platelet GP Ib/IX/V complex: physiological role.

Authors:  J Rivera; M L Lozano; J Corral; R González-Conejero; C Martínez; V Vicente
Journal:  J Physiol Biochem       Date:  2000-12       Impact factor: 4.158

5.  A histopathological comparison of different definitions for quantifying in-stent neointimal tissue: implications for the validity of intracoronary ultrasound and optical coherence tomography measurements.

Authors:  Pedro A Lemos; Celso K Takimura; Francisco R M Laurindo; Paulo S Gutierrez; Vera D Aiello
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

6.  Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis.

Authors:  H Douglas; K Michaelides; D A Gorog; E Durante-Mangoni; N Ahmed; G J Davies; E G D Tuddenham
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

7.  The association of platelet GPIb alpha 145 Thr/Met (HPA-2a/2b) with myocardial infarction and coronary artery disease.

Authors:  Marlena Culjak Aleksic; Jasna Mesaric
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

8.  Molecular genetics of myocardial infarction.

Authors:  Yoshiji Yamada; Sahoko Ichihara; Tamotsu Nishida
Journal:  Genomic Med       Date:  2008-08-14

9.  Single nucleotide polymorphism network: a combinatorial paradigm for risk prediction.

Authors:  Puspita Das Roy; Dhriti Sengupta; Anjan Kr Dasgupta; Sudip Kundu; Utpal Chaudhuri; Indranil Thakur; Pradipta Guha; Mousumi Majumder; Roshni Roy; Bidyut Roy
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

10.  Body mass index and waist/height ratio for prediction of severity of coronary artery disease.

Authors:  Khandker Md Nurus Sabah; Abdul Wadud Chowdhury; H I Luftur Rahman Khan; A T M Hasibul Hasan; Serajul Haque; Shomsher Ali; Shamima Kawser; Nur Alam; Gaffar Amin; S M Ear E Mahabub
Journal:  BMC Res Notes       Date:  2014-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.